Search results
Results from the WOW.Com Content Network
Data from Switzerland, for example, demonstrated a decline in the prevalence of analgesic nephropathy among people with end-stage kidney disease, from 28% in 1981 to 12% in 1990. [4] An autopsy study performed in Switzerland suggested that the prevalence of analgesic nephropathy in the general population has likewise decreased; the prevalence ...
Patients are advised to discuss any history of bone issues, kidney issues, or hepatitis B infection with their healthcare provider. [19] Effectiveness of PrEP for prevention of infection is reliant on an individual's ability to take the medication consistently. [20] Emtricitabine/tenofovir is also used for HIV post-exposure prophylaxis. People ...
Tenofovir disoproxil is a pro-drug form of tenofovir phosphonate, which is liberated intracellularly and converted to tenofovir disphophate. [32] It is marketed by Gilead Sciences (as the fumarate, abbreviated TDF). [33] Tenofovir disoproxil is also available in pills which combine a number of antiviral drugs into a single dose.
It is characterized by the following symptoms: deep and rapid breathing, tiredness or weakness, nausea, vomiting, abnormal muscle pain, dizziness or drowsiness; Serious liver problems, such as hepatomegaly (enlarged liver) and steatosis (fatty liver).
The various symptoms of acute kidney injury result from the various disturbances of kidney function that are associated with the disease. Accumulation of urea and other nitrogen-containing substances in the bloodstream lead to a number of symptoms, such as fatigue , loss of appetite , headache , nausea , and vomiting . [ 6 ]
It is used for the treatment of chronic hepatitis B virus (HBV) infection in adults with compensated liver disease [8] and is given in combination with other medications for the prevention and treatment of HIV. It is taken by mouth. [6] Tenofovir alafenamide is a nucleotide reverse transcriptase inhibitor and is a prodrug of tenofovir.
It is on the World Health Organization's List of Essential Medicines. [4] In some countries it is available as a generic medication. [5] It is tentatively approved in the United States as of 2019, full approval is pending expiration of the US patents on dolutegravir (Tivicay) and tenofovir disoproxil (Viread). [6] [7]
Kidney infarction: CT scan of the abdomen showing partial infarct of the left kidney. Specialty: Nephrology: Symptoms: Abdominal pain, nausea, vomiting, and fever. [1] Complications: Acute kidney injury and chronic kidney disease. [1] Causes: Cardioembolic disease, renal artery injury, and hypercoagulable state. [1] Diagnostic method